The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion
Abstract As a strategy to improve the therapeutic success of chimeric antigen receptor T cells (CART) directed against solid tumors, we here test the combinatorial use of CART and IMSA101, a newly developed stimulator of interferon genes (STING) agonist. In two syngeneic tumor models, improved overa...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-47692-9 |